Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3463773

COc1cc(F)c(C(Nc2ccc(C(=N)N)cc2)C(=O)NNC(=O)c2ccccn2)cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 9/20 0.46
PRSS1 P07477 9/20 0.46
F7 P08709 9/20 0.46
F10 P00742 8/20 0.46
PRSS2 P07478 2/20 0.46
F3 P13726 2/20 0.46
PRSS3 P35030 2/20 0.46
GRM4 Q14833 2/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 2/20 0.43
AURKB Q96GD4 1/20 0.42
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40
CDK5 Q00535 1/20 0.40
PAX8 Q06710 1/20 0.40
CDK5R1 Q15078 1/20 0.40
TLR7 Q9NYK1 3/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13162845 0.95 GRM4 (0.48) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3463948 0.89 F7 (0.48) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3463465 0.89 F7 (0.49) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3465593 0.88 F7 (0.43) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL4911664 0.88 F2 (0.44) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3463872 0.88 F7 (0.43) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3464509 0.88 PRSS1 (0.46) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3464956 0.87 F7 (0.47) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3463952 0.87 PRSS1 (0.42) F2PRSS1F7F10PRSS2
Trifluoroacetic Acid SCHEMBL3464880 0.87 F2 (0.43) F2PRSS1F7F10PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240654-A1 HYDRAZIDE DERIVATIVES CLARK RICHARD 2010-09-23 US disclosed
US-20080132507-A1 Hydrazide Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-06-05 US disclosed
EP-1810965-A1 HYDRAZIDE DERIVATIVES Eisai R&D Management Co., Ltd. (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240654-A1 HYDRAZIDE DERIVATIVES H1-10, H1-4, H1-3 F2 19/4885PRSS1 727/4885F7 185/4885
US-20080132507-A1 Hydrazide Derivatives H1-10, H1-4, H1-3 F2 19/4885PRSS1 727/4885F7 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.